You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
健世科技-B(09877.HK):Ken-Valve成功完成首批商業化植入

格隆匯7月21日丨健世科技-B(09877.HK)發佈公告,公司核心產品之一經導管主動脈瓣置換(“TAVR”)產品Ken-Valve已於全國重點省市地區的一系列醫院成功完成首批商業化植入,最大使用瓣膜型號爲33mm,最短器械操作時間約5分鐘。在剛剛結束的2025華西微創心血管大會暨第八屆西部瓣膜論壇中,Ken-Valve順利完成多例手術直播,成功爲多位解剖結構複雜,其中包括超大瓣環、大橫位心的患者,完成主動脈瓣介入置換術。Ken-Valve設計特點、操作優勢、適用範圍獲得與會專家的熱烈討論和關注。

Ken-Valve是公司自主開發的第一代經導管主動脈瓣置換系統,爲治療重度主動脈瓣反流或合併主動脈瓣狹窄的患者而設計。Ken-Valve是市場上較爲稀缺的治療主動脈瓣反流(或合併狹窄)的TAVR產品。Ken-Valve採用一體式夾持定位鍵設計,提高瓣膜固定穩定性;輸送系統具備主動調彎設計,有效提升瓣膜植入同軸性;擁有最大可達33mm的多個瓣膜規格型號,能夠滿足廣泛未被滿足的超大瓣環主動脈瓣反流或合併狹窄患者的迫切臨牀需求。

首批商業化植入的成功開展標誌着Ken-Valve在中國的商業化應用成功啓動及順利推進,爲該產品及公司商業化進程的重要里程碑。公司將繼續採取多種措施,抓住市場機遇,擴大銷售網絡,不斷推進包括Ken-Valve、LuX-Valve系列產品在內的公司核心產品全球商業化進程;同時,公司將持續優化生產成本及營運效率,於實際可行情況下儘快實現公司的收入目標。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account